266 related articles for article (PubMed ID: 24433729)
21. Aneurysmal bone cyst and giant cell tumor of bone of the hand and distal radius.
Athanasian EA
Hand Clin; 2004 Aug; 20(3):269-81, vi. PubMed ID: 15275686
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.
Han YH; Gao B; Huang JH; Wang Z; Guo Z; Jie Q; Yang L; Luo ZJ
Int J Clin Exp Pathol; 2015; 8(7):8446-52. PubMed ID: 26339416
[TBL] [Abstract][Full Text] [Related]
23. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components.
Çomunoğlu N; Kepil N; Dervişoğlu S
Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920
[TBL] [Abstract][Full Text] [Related]
24. Fibular giant cell-rich osteosarcoma virtually indistinguishable radiographically and histopathologically from giant cell tumor-analysis of subtle differentiating features.
Chow LT
APMIS; 2015 Jun; 123(6):530-9. PubMed ID: 25907659
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
26. A clinicopathological study of giant cell tumor of small bones.
Yanagisawa M; Okada K; Tajino T; Torigoe T; Kawai A; Nishida J
Ups J Med Sci; 2011 Nov; 116(4):265-8. PubMed ID: 21919814
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspiration diagnosis of aggressive giant cell tumor of bone. A case report.
Ríos-Martín J; Otal-Salaverri C; Vázquez-Ramírez FJ; González-Cámpora R; Davidson HG
Acta Cytol; 1995; 39(3):550-4. PubMed ID: 7762351
[TBL] [Abstract][Full Text] [Related]
28. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
29. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
Wen J; Xie D; Yao J; Zhang M; Bi J
Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
[TBL] [Abstract][Full Text] [Related]
30. [GIANT CELL TUMOR OF BONE: RESULTS AND TREATMENT COMPLICATIONS].
Bergovec M; Petković M; Smerdelj M; Seiwerth S; Brkić L; Robert K; Orlić D
Acta Med Croatica; 2014 Dec; 68(4-5):405-10. PubMed ID: 26285474
[TBL] [Abstract][Full Text] [Related]
31. De novo malignant transformation of giant cell tumor of bone.
Marui T; Yamamoto T; Yoshihara H; Kurosaka M; Mizuno K; Akamatsu T
Skeletal Radiol; 2001 Feb; 30(2):104-8. PubMed ID: 11310196
[TBL] [Abstract][Full Text] [Related]
32. [Histogenesis of giant cell tumors].
Wuelling M; Engels C; Jesse N; Werner M; Kaiser E; Delling G
Pathologe; 2002 Sep; 23(5):332-9. PubMed ID: 12376858
[TBL] [Abstract][Full Text] [Related]
33. Giant cell tumors of the temporal bone and infratemporal fossa: a case report and review of the literature.
Roberts DS; Faquin WC; Deschler DG
Laryngoscope; 2010; 120 Suppl 4():S180. PubMed ID: 21225778
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of p53 protein expression in giant cell tumor of bone.
Yalcinkaya U; Ugras N; Kabul S; Ocakoglu G; Bilgen MS
Pol J Pathol; 2015 Dec; 66(4):389-96. PubMed ID: 27003771
[TBL] [Abstract][Full Text] [Related]
36. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
37. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
[No Abstract] [Full Text] [Related]
38. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
39. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
40. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.
Al-Ibraheemi A; Inwards CY; Zreik RT; Wenger DE; Jenkins SM; Carter JM; Boland JM; Rose PS; Jin L; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2016 Dec; 40(12):1702-1712. PubMed ID: 27526293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
